For example, previous research demonstrated that silencing of PYCR1 inhibited proliferation, invasive migration capability, epithelial-mesenchymal transition, and metastatic abilities in hepatocellular carcinoma (HCC) (Guo et al. 2021). This evidence concerns the gene PYCR1 and hepatocellular carcinoma.